High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer

Oncotarget

Volumn 7, Issue 4, 2016, Pages 4611-4623

  Leidinger, Petra ^a   Brefort, Thomas ^b   Backes, Christina ^c   Krapp, Medea ^b   Galata, Valentina ^c   Beier, Markus ^b   Kohlhaas, Jochen ^b   Huwer, Hanno ^c   Meese, Eckart ^a   Keller, Andreas ^c  

^a SAARLAND UNIVERSITY   (Germany)

^b The Comprehensive Biomarker Center GmbH   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

Diagnosis; miRNA; NSCLC; qRT PCR

Indexed keywords

BIOLOGICAL MARKER; HSA LET 7A 5P; HSA LET 7D 5P; HSA LET 7E 5P; HSA LET 7F 5P; HSA LET 7G 5P; HSA MICRORNA 106A 5P; HSA MICRORNA 1180 3P; HSA MICRORNA 1224 3P; HSA MICRORNA 126 3P; HSA MICRORNA 146B 5P; HSA MICRORNA 17 5P; HSA MICRORNA 18A 3P; HSA MICRORNA 19A 3P; HSA MICRORNA 20A 5P; HSA MICRORNA 20B 5P; HSA MICRORNA 21 5P; HSA MICRORNA 26A 5P; HSA MICRORNA 29C 3P; HSA MICRORNA 29C 5P; HSA MICRORNA 30C 5P; HSA MICRORNA 328 3P; HSA MICRORNA 378A 5P; HSA MICRORNA 942 5P; MICRORNA; UNCLASSIFIED DRUG; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CANCER SCREENING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; GENE EXPRESSION REGULATION; HIGH THROUGHPUT SCREENING; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NON SMALL CELL LUNG CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; UPREGULATION; VALIDATION STUDY; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; LUNG TUMOR; MALE; MIDDLE AGED; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION;

AGED; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84958025571     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.6566     Document Type: Article

References (22)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65:87-108.
2. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136:215-233.
3. Qin X, Xu H, Gong W, Deng W. The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer. Front Oncol. 2014; 4:357.
4. Joerger M, Baty F, Fruh M, Droege C, Stahel RA, Betticher DC, von Moos R, Ochsenbein A, Pless M, Gautschi O, Rothschild S, Brauchli P, Klingbiel D, et al. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05). Lung Cancer. 2014; 85:306-313.
5. Keller A, Leidinger P, Steinmeyer F, Stahler C, Franke A, Hemmrich-Stanisak G, Kappel A, Wright I, Dorr J, Paul F, Diem R, Tocariu-Krick B, Meder B, et al. Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Mult Scler. 2014; 20:295-303.
6. Leidinger P, Backes C, Blatt M, Keller A, Huwer H, Lepper P, Bals R, Meese E. The blood-borne miRNA signature of lung cancer patients is independent of histology but influenced by metastases. Mol Cancer. 2014; 13:202.
7. Keller A, Leidinger P, Vogel B, Backes C, ElSharawy A, Galata V, Müller S, Marquart S, Schrauder M, Strick R, Bauer A, Wischhusen J, Beier M, et al. miRNAs can be generally associated with human pathologies as exemplified for miR-144. BMC Med. 2014; 12:224.
8. Leidinger P, Backes C, Deutscher S, Schmitt K, Mueller SC, Frese K, Haas J, Ruprecht K, Paul F, Stahler C, Lang CJ, Meder B, Bartfai T, et al. A blood based 12-miRNA signature of Alzheimer disease patients. Genome biology. 2013; 14:R78.
9. Margue C, Reinsbach S, Philippidou D, Beaume N, Walters C, Schneider JG, Nashan D, Behrmann I, Kreis S. Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer? Oncotarget. 2015; 6:12110-12127. doi:10.18632/oncotarget.3661.
10. Ma J, Lin Y, Zhan M, Mann DL, Stass SA, Jiang F. Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer. Lab Invest. 2015; 95:1197-9497.
11. Keller A, Leidinger P, Borries A, Wendschlag A, Wucherpfennig F, Scheffler M, Huwer H, Lenhof HP, Meese E. miRNAs in lung cancer-studying complex fingerprints in patient's blood cells by microarray experiments. BMC cancer. 2009; 9:353.
12. Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, Backes C, Wendschlag A, Giese N, Tjaden C, Ott K, Werner J, Hackert T, Ruprecht K, et al. Toward the blood-borne miRNome of human diseases. Nature methods. 2011; 8:841-843.
13. Leidinger P, Keller A, Borries A, Huwer H, Rohling M, Huebers J, Lenhof H-P, Meese E. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer. 2011; 74:41-47.
14. Andersen CL, Jensen JL, Orntoft TF. Normalization of realtime quantitative reverse transcription-PCR data: a modelbased variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004; 64:5245-5250.
15. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell research. 2008; 18:997-1006.
16. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer. 2011; 6:482-488.
17. Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Lung cancer. 2013; 81:388-396.
18. Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, Mei Y, Guarnera M, Liao J, Chou A, Lu CL, Jiang Z, Fang H, Katz RL et al. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Laboratory investigation; a journal of technical methods and pathology. 2011; 91: 579-587.
19. Jeong HC, Kim EK, Lee JH, Lee JM, Yoo HN, Kim JK. Aberrant expression of let-7a miRNA in the blood of nonsmall cell lung cancer patients. Molecular medicine reports. 2011; 4:383-387.
20. Leidinger P, Keller A, Borries A, Huwer H, Rohling M, Huebers J, Lenhof HP, Meese E. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung cancer. 2011; 74:41-47.
21. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, Tait JF, Tewari M. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer prevention research. 2012; 5:492-497.
22. Leidinger P, Backes C, Dahmke IN, Galata V, Huwer H, Stehle I, Bals R, Keller A, Meese E. What makes a blood cell based miRNA expression pattern disease specific?-a miRNome analysis of blood cell subsets in lung cancer patients and healthy controls. Oncotarget. 2014; 5:9484-9497. doi:10.18632/oncotarget.2419.